For the latest openings visit the Careers section of our website CPL Biologicals launches Cadiflu-S,World`s First Virus Like Particle(VLP) Vaccine for Seasonal Influenza
The public at large is cautioned of fraudulent activities and false commitments using the name of Cadila.

News & Events

  • CPL Biologicals launches Cadiflu-S, World’s First Virus Like Particle (VLP) Vaccine for Seasonal Influenza Read More >>


A result of in-house Research and Development initiatives and collaborations with world-renowned institutions; Cadila Pharmaceuticals’ product basket includes: branded and generic formulations covering more than 50 therapeutic segments; Biotechnology products and diagnostic kits, Plant Tissue Culture, etc. In the services realm, the gamut of offerings covers Clinical Research, Contract Research & Manufacturing, etc.

Cadila Pharmaceuticals is the only Indian manufacturer of Streptokinase and Hyaluronic Acid-based products. Hyaluronic Acid containing products include Visial for Ophthalmology and Halonix for intra articular use. Streptokinase is used in management of heart attack. The company also manufactures rabies immunoglobin and diagnostic kits for detection of HIV and HCV. Cadila Pharmaceuticals is working in areas of novel vaccine adjuvants, Sepsis management and therapeutic vaccine for pancreatic cancer. Group companies also manufacture Tablet Presses, Capsule filling machines, pharma machinery parts and hospital disposables like gloves, etc.

To the World from Cadila Pharmaceuticals

  • World’s first Sparfloxacin Eye Drops (Scat Eye Drops)
  • World’s first parenteral formulation of Rabeprazole (Rabeloc I.V.)
  • World’s first Probiotic combined with anti-infective agent (Symbiotic)
  • World’s first manufacturer of a unique immunomodulator (IMMUVAC)
  • World’s first whole blood, rapid HIV detection kit (NEVA HIV)


 |  API Product List

Counterfeit Drugs: In case of any information on /or availability of counterfeit products... Read More © 2019 Cadila Pharmaceuticals all right reserved
Corporate identification No : U24231GJ1991PLC015132
Cadila Pharmaceuticals